Search
Cannabigerol
go.drugbank.com/drugs/DB14734InvestigationalA natural product found in Cannabis sativa and Helichrysum species.
Cannabichromene
go.drugbank.com/drugs/DB14735InvestigationalA natural product found in Cannabis sativa and Helichrysum species.
Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesSynonyms: 2-Methyl-2-(4-methyl-3-pentenyl)-7-pentyl-2H-1-benzopyran-5-olCannabinol
go.drugbank.com/drugs/DB14737InvestigationalCannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 CYP1A2 InhibitorsSynonyms: 6,6,9-Trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-olHyaluronidase
go.drugbank.com/drugs/DB14740ApprovedInvestigational[A199026] Early research into hyaluronidase identified it as a "spreading factor" which allowed for increased permeability of the connective tissue. … [A199047] Hyaluronidase was first used in prescription products in the United States on 5 May 2004.[L13338]
Products: HYLASE® DESSAU 150 IU, POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION PARA ADMINISTRACIÓN OFTALMICAMecasermin rinfabate
go.drugbank.com/drugs/DB14751ApprovedInvestigationalIn 2007 Insmed withdrew their application for a marketing authorization with The European Medicines Agency[F4075]. … The binding of IGF-1 to IGFBP-3 is said to extend the half life and reduce the clearance of IGF-1 in patients with growth hormone resistant syndromes and low levels of IGFBP-3 though this may represent
Synonyms: rhIGF-I/rhIGFBP-3, Recombinant human insulin-like growth factor-I/insulin-like growth factor binding protein-3Catfish
go.drugbank.com/drugs/DB14758ApprovedCatfish (unspecified) allergenic extract is used in allergenic testing.
Red pepper
go.drugbank.com/drugs/DB14759ApprovedRed pepper allergenic extract is used in allergenic testing.
Narlaprevir
go.drugbank.com/drugs/DB14760InvestigationalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesLanraplenib
go.drugbank.com/drugs/DB14770InvestigationalLanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)
go.drugbank.com/drugs/DB14771InvestigationalPolyacrylamide (crosslinked; 2 mole percent bisacrylamide) is under investigation in clinical trial NCT00629083 (Bulking Agents for the Treatment of Stress Urinary Incontinence in Females).
Synonyms: Polyacrylamide (crosslinked; 2 mole percent bisacrylamide)